Structure-based discovery of pyrazolobenzothiazine derivatives as inhibitors of hepatitis C virus replication. 2013

Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
Dipartimento di Chimica e Tecnologia del Farmaco, Sezione di Chimica Farmaceutica II, Università degli Studi di Perugia, Via del Liceo 1, 06123 Perugia, Italy. lbarreca@unipg.it

The NS5B RNA-dependent RNA polymerase is an attractive target for the development of novel and selective inhibitors of hepatitis C virus replication. To identify novel structural hits as anti-HCV agents, we performed structure-based virtual screening of our in-house library followed by rational drug design, organic synthesis, and biological testing. These studies led to the identification of pyrazolobenzothiazine scaffold as a suitable template for obtaining novel anti-HCV agents targeting the NS5B polymerase. The best compound of this series was the meta-fluoro-N-1-phenyl pyrazolobenzothiazine derivative 4a, which exhibited an EC50 = 3.6 μM, EC90 = 25.6 μM, and CC50 > 180 μM in the Huh 9-13 replicon system, thus providing a good starting point for further hit evolution.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins

Related Publications

Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
May 2009, Journal of medicinal chemistry,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
June 2016, European journal of medicinal chemistry,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
July 2009, Bioorganic & medicinal chemistry letters,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
December 2000, Bioorganic & medicinal chemistry letters,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
March 2014, Journal of medicinal chemistry,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
March 2014, Journal of medicinal chemistry,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
November 2003, Journal of viral hepatitis,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
August 2020, Journal of medicinal chemistry,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
September 2006, Antiviral research,
Maria Letizia Barreca, and Giuseppe Manfroni, and Pieter Leyssen, and Johan Winquist, and Neerja Kaushik-Basu, and Jan Paeshuyse, and Ramalingam Krishnan, and Nunzio Iraci, and Stefano Sabatini, and Oriana Tabarrini, and Amartya Basu, and U Helena Danielson, and Johan Neyts, and Violetta Cecchetti
May 2015, Organic & biomolecular chemistry,
Copied contents to your clipboard!